All for Joomla All for Webmasters

Anti-beta-2 glycoprotein I epitope specificity: from experimental models to diagnostic tools

Rate this item
(0 votes)

Utility:

Antibodies targeting B2GPI-DI are more frequently detected in patients with full-blown APS compared to asymptomatic aPL carriers or patients with infectious diseases who have antibodies directed against the whole molecule; anti-DI antibodies are positively correlated with medium to high titers of aPL, with the presence of lupus anticoagulant and thrombotic and pregnancy manifestations, enabling identification of patients at higher risk of clinical events

Additional Info

Read 171 times

Werfen.com. All rights Reserved. Privacy Policy | Cookies Policy | Terms of Service

No Internet Connection